Explore the latest developments concerning FDA recalls levothyroxine.
FDA recalls levothyroxine sodium tablets. Here's what to know
Recalls occur when manufacturers and distributors remove products “that present a risk of injury or gross deception or are otherwise defective,” according to the FDA.
The Food and Drug Administration has recalled a commonly prescribed thyroid medication.
The recall involves levothyroxine sodium tablets that are used to treat hypothyroidism and decrease the size of enlarged thyroid glands, according to Mayo Clinic.
Stream San Diego News for free, 24/7, wherever you are with NBC 7.
The FDA said they had been functioning as "subpotent drugs," meaning they had less of an active ingredient and were ultimately less effective.
Major Pharmaceuticals packaged and distributed the recalled tablets, while Cardinal Health also distributed some of the recalled products.
Nationwide recall issued for this thyroid medication. See products
Major Rugby, a pharmaceutical manufacturer that produces levothyroxine sodium tablets, issued a nationwide recall for the common thyroid medication, according to a letter it sent to retailers earlier this month.
While consumers are being urged to return their medicine to the point of purchase, Major Rugby said in its letter that taking them "is not likely to cause adverse health effects."
Here’s what you should know about the recalled products and how to identify them.
Major Rugby issued a recall for 12 of its levothyroxine sodium tablet packages, including individual packs of 10 and boxes containing 10 blister packs.
The Mayo Clinic notes that levothyroxine sodium tablets are used to treat hypothyroidism, enlarged thyroid glands and a type of thyroid cancer.
JHK Bedside Table For Bedroom With 10 Fabric Drawers Wardrobe Steel Frame Closet For Storage Cabinet Living Room Of Furniture
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.
For more detailed information, explore updates concerning FDA recalls levothyroxine.